Sowa Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-410
Closed -$25K 93
2020
Q4
$25K Hold
410
0.02% 168
2020
Q3
$25K Hold
410
0.02% 157
2020
Q2
$24K Hold
410
0.02% 155
2020
Q1
$23K Hold
410
0.02% 145
2019
Q4
$26K Buy
+410
New +$23.5K 0.02% 151

Other funds holding BMY

Sowa Financial Group's BMY Position: Q1 2021 in Review

Sowa Financial Group sold out of Bristol-Myers Squibb (BMY) in Q1 2021, closing a stake of 410 shares — an estimated $25K sold.

Sowa Financial Group first reported a position in BMY in Q4 2019 and held it in 5 quarters. The position peaked at $26K in Q4 2019. 2,368 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

  • Sowa Financial Group reported no remaining Bristol-Myers Squibb position as of Q1 2021 after selling out during the quarter.
  • Sowa Financial Group sold 410 Bristol-Myers Squibb shares in Q1 2021, an estimated $25K.
  • Sowa Financial Group first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 5 quarters.
  • Sowa Financial Group's Bristol-Myers Squibb position peaked at $26K in Q4 2019.
  • 2,368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on Sowa Financial Group's 13F filing for Q1 2021, filed 7 Apr 2021.